AGX insider nets 8,493 shares from option exercise; gifts and transfer
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Argan, Inc. (AGX) director Peter W. Getsinger reported insider transactions on Form 4. On October 15, 2025, he exercised an option to purchase 10,000 shares at $46.35 per share using a net settle method, resulting in 8,493 shares acquired. That same day, he gifted 333 shares to each of his three children, totaling 999 shares. On October 16, 2025, he transferred 1,000 shares to a donor advised fund managed by Martha's Vineyard Investment Advisors.
Following these transactions, his directly held position was 18,390 shares. The option was originally awarded on January 11, 2018, became exercisable on January 11, 2019, and has an expiration date of January 11, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
10,000 shares exercised/converted
Mixed
4 txns
Insider
Getsinger Peter W
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 1,000 | $0.00 | -- |
| Exercise | Option to Purchase Common Stock | 10,000 | $46.35 | $464K |
| Exercise | Common Stock | 8,493 | $46.35 | $394K |
| Gift | Common Stock | 999 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 18,390 shares (Direct);
Option to Purchase Common Stock — 21,500 shares (Direct)
Footnotes (1)
- On October 15, 2025, the Reporting Person exercised his stock option awarded on January 11, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $46.35 per share, using the net settle method. On October 15, 2025, the Reporting Person gifted 333 shares to each of his three children. On October 16, 2025, the Reporting Person transferred 1,000 shares of the Issuer's common stock to a donor advised fund managed by Martha's Vineyard Investment Advisors.
FAQ
What insider transaction did AGX director Peter W. Getsinger report?
He exercised an option for 10,000 shares at $46.35 per share on October 15, 2025 using a net settle method.
What were the option’s key dates and terms?
The option was awarded on January 11, 2018, became exercisable on January 11, 2019, expires on January 11, 2028, and had an exercise price of $46.35.
Were the gifts priced transactions?
Gift transactions were reported at $0 in the filing tables.
What is the ownership form after the transactions?
The filing shows direct ownership of 18,390 shares following the reported transactions.